Animal model of undernutrition for the evaluation of drug pharmacokinetics

被引:0
|
作者
Merino-Sanjuan, M. [1 ,2 ]
Catalan-Latorre, A. [2 ]
Nacher, A. [2 ]
Miralles-Arnau, S. [2 ]
Jimenez-Torres, N. V. [2 ,3 ]
机构
[1] Univ Valencia, Fac Pharm, Dept Pharm & Pharmaceut Technol, Inst Mol Recognit & Technol Dev IDM,Polithecn Uni, E-46100 Valencia, Spain
[2] Univ Valencia, Fac Pharm, Dept Pharm Technol, E-46100 Valencia, Spain
[3] Dr Peset Univ Hosp, Serv Pharm, Valencia, Spain
关键词
Undernutrition; Rat; Animal model; Coding; MALNUTRITION; RATS; PERMEABILITY; GROWTH; DIET;
D O I
10.3305/nh.2011.26.6.5403
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Protein energy malnutrition is a public health problem affecting a great number of people. Pathophysiological imbalances in malnourished individuals have a profound impact on drug pharmacokinetics. Objective: To develop an animal model of undernutrition using male Wistar rats to be used to assess, in further studies, the impact of nutritional status on the oral bioavailability and pharmacokinetics of drugs. Desing: Animals were randomly assigned to one of two groups and fed different diets for 26 days: WN (well-nourished/regular diet, N = 61) and UN (under-nourished/protein-calorie restricted diet, N = 72). Assessment of the animals' nutritional status was performed taking into account serum albumin, total cholesterol level and total body weight. A kinetic model incorporating population kinetic analysis (NONMEM) was developed to analyze body weight versus time profiles in the adaptation period following administration of the two aforementioned diets. Results: Serum albumin plasma levels were lower than 2.3 g/dL in 80% (60/72) of malnourished animals at the end of the adaptation period. The range of the total serum cholesterol was similar in both groups at the end of the adaptation period. Total body weight in all cases was less than 230 g for malnourished animals and higher than 240 g for well-nourished animals. The kinetic model assayed was confirmed to be an expansion module characterized by linear weight gain and a decline module characterized by exponential weight loss, where the weight loss rate constant is an exponential function of time. The bootstrap resampling method confirmed the stability of the model eventually selected. Conclusions: The animal model developed in this study is reliable and could be of use in evaluating the impact of nutritional state on the pharmacokinetics of drugs. The proposed mathematical model allows the body weight of animals to be predicted at a given time taking into account the diet followed in the experimental period. (Nutr Hosp. 2011;26:1296-1304)
引用
收藏
页码:1296 / 1304
页数:9
相关论文
共 50 条
  • [21] Evaluation of reward processes in an animal model of depression
    David A. Slattery
    Athina Markou
    John F. Cryan
    Psychopharmacology, 2007, 190 : 555 - 568
  • [22] Evaluation of the Effect of Duration on the Efficacy of Pulsed Radiofrequency in an Animal Model of Neuropathic Pain
    Ramzy, Eiad A.
    Khalil, Khaled I.
    Nour, Eman M.
    Hamed, Mohammed F.
    Taha, Mohamed A.
    PAIN PHYSICIAN, 2018, 21 (02) : 191 - 198
  • [23] New Regenerative Vascular Grafts for Hemodialysis Access: Evaluation of a Preclinical Animal Model
    Valencia Rivero, Karen Tatiana
    Jaramillo Escobar, Juliana
    Galvis Forero, Sergio David
    Miranda Saldana, Maria Clara
    Lopez Panqueva, Rocio del Pilar
    Sandoval Reyes, Nestor Fernando
    Briceno Triana, Juan Carlos
    JOURNAL OF INVESTIGATIVE SURGERY, 2018, 31 (03) : 192 - 200
  • [24] Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data
    del Amo, Eva M.
    Urtti, Arto
    EXPERIMENTAL EYE RESEARCH, 2015, 137 : 111 - 124
  • [25] Animal Models of Undernutrition and Enteropathy as Tools for Assessment of Nutritional Intervention
    Salameh, Emmeline
    Morel, Fanny B.
    Zeilani, Mamane
    Dechelotte, Pierre
    Marion-Letellier, Rachel
    NUTRIENTS, 2019, 11 (09)
  • [26] Animal models for transdermal drug delivery
    Panchagnula, R
    Stemmer, K
    Ritschel, WA
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1997, 19 (05): : 335 - 341
  • [27] Animal models for drug discovery in dystonia
    Jinnah, H. A.
    Richter, Angelika
    Mink, Jonathon W.
    Caldwell, Guy A.
    Caldwell, Kim A.
    Gonzalez-Alegre, Pedro
    Cookson, Mark R.
    Breakefield, Xandra O.
    Delong, Mahlon R.
    Hess, Ellen J.
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (01) : 83 - 97
  • [28] Animal models of alcohol and drug dependence
    Planeta, Cleopatra S.
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2013, 35 : S140 - S146
  • [29] Silkworm as a model animal to evaluate drug candidate toxicity and metabolism
    Hamamoto, Hiroshi
    Tonoike, Akiko
    Narushima, Kazuya
    Horie, Ryo
    Sekimizu, Kazuhisa
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2009, 149 (03): : 334 - 339
  • [30] Effect of the New Antiepileptic Drug Levetiracetam in an Animal Model of Mania
    Lamberty, Yves
    Margineanu, Doru Georg
    Klitgaard, Henrik
    EPILEPSY & BEHAVIOR, 2001, 2 (05) : 454 - 459